| scholarly article | Q13442814 |
| P50 | author | Heidi M Feldman | Q63979470 |
| Mary Amanda Dew | Q87012500 | ||
| Jerry Vockley | Q42112236 | ||
| George Mazariegos | Q42906177 | ||
| P2093 | author name string | D H Morton | |
| A DeVito Dabbs | |||
| R B Noll | |||
| K A Strauss | |||
| D A Shellmer | |||
| P2860 | cites work | Elective liver transplantation for the treatment of classical maple syrup urine disease. | Q46936591 |
| Social outcome in adults with maple syrup urine disease (MSUD). | Q48268538 | ||
| Academic outcome in long-term survivors of pediatric liver transplantation | Q48703576 | ||
| Assessment of psychoeducational outcomes after pediatric liver transplant. | Q51945064 | ||
| Cognitive performance of children who have undergone liver transplantation | Q51949070 | ||
| Mental and motor development, social competence, and growth one year after successful pediatric liver transplantation. | Q52066086 | ||
| Intellectual outcome in children with maple syrup urine disease. | Q52236268 | ||
| Intellectual performance of children with maple syrup urine disease | Q70587647 | ||
| Outcome of early and long-term management of classical maple syrup urine disease | Q71583458 | ||
| [Advances in the diagnosis and treatment of maple syrup urine disease: experience in Galicia (Spain)] | Q81468899 | ||
| Neuropsychometric outcome predictors for adults with maple syrup urine disease | Q83120640 | ||
| Cognitive development following pediatric solid organ transplantation | Q37559219 | ||
| Cognitive function in children who receive organ transplantation | Q40745640 | ||
| Diagnosis and treatment of maple syrup disease: a study of 36 patients | Q44013322 | ||
| Developmental profile of patients with maple syrup urine disease | Q45921973 | ||
| Metabolic correlates of learning disability. | Q46020760 | ||
| Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD. | Q46835000 | ||
| P433 | issue | 1 | |
| P921 | main subject | maple syrup urine disease | Q402575 |
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 58-64 | |
| P577 | publication date | 2010-10-08 | |
| P1433 | published in | Pediatric Transplantation | Q7159217 |
| P1476 | title | Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series | |
| P478 | volume | 15 |
| Q48281291 | A case of classical maple syrup urine disease that was successfully managed by living donor liver transplantation. |
| Q37333950 | Achieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework |
| Q37002969 | Adaptive functioning and its correlates after intestine and liver transplantation |
| Q37640465 | Adipose transplant for inborn errors of branched chain amino acid metabolism in mice |
| Q36733516 | Biochemical correlates of neuropsychiatric illness in maple syrup urine disease |
| Q33617530 | Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease |
| Q34222287 | Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders. |
| Q92930679 | Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes |
| Q38219782 | Child and family adjustment following pediatric solid organ transplantation: factors to consider during the early years post-transplant. |
| Q50717230 | Cognitive performance in pediatric liver transplant recipients |
| Q93000066 | Discovery of Biomarker Panels for Neural Dysfunction in Inborn Errors of Amino Acid Metabolism |
| Q38069846 | Domino liver transplantation in maple syrup urine disease: a case report and review of the literature. |
| Q88611012 | Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease |
| Q95353303 | Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, He |
| Q53809440 | Heterozygote to homozygote related living donor liver transplantation in maple syrup urine disease: a case report. |
| Q36900920 | Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience |
| Q38185194 | Liver transplantation for pediatric metabolic disease |
| Q48964541 | Living related versus deceased donor liver transplantation for maple syrup urine disease. |
| Q48002467 | Maple syrup urine disease (MSUD): a case with long-term follow-up after liver transplantation |
| Q36703069 | Neuropsychiatric Symptoms in Inborn Errors of Metabolism: Incorporation of Genomic and Metabolomic Analysis into Therapeutics and Prevention |
| Q30487009 | Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach |
| Q33861034 | Successful domino liver transplantation in maple syrup urine disease using a related living donor |
| Q33632216 | The start of the transplant journey: referral for pediatric solid organ transplantation. |
| Q37972714 | Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. |
| Q36571556 | Two consecutive partial liver transplants in a patient with Classic Maple Syrup Urine Disease |
Search more.